• Fund Type: Open-End Fund
  • Objective: Market Neutral
  • Asset Class: Equity
  • Geographic Focus: U.S.

Rydex Series - Health Care Fund

+ Add to Watchlist

RYHCX:US

25.14 USD 0.20 0.80%

As of 09:29:30 ET on 07/22/2014.

Snapshot for Rydex Series - Health Care Fund (RYHCX)

Year To Date: +8.77% 3-Month: +6.58% 3-Year: +17.46% 52-Week Range: 20.23 - 25.60
1-Month: -0.40% 1-Year: +20.87% 5-Year: +18.20% Beta vs SPX: 0.93

Mutual Fund Chart for RYHCX

No chart data available.
  • RYHCX:US 25.14
  • 1M
  • 1Y
Interactive RYHCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RYHCX

Rydex Series-Health Care Fund is an open-end fund incorporated in the USA. The Fund's objective is to provide capital appreciation. The Fund invests substantially all of its assets in equity securities of health care companies that are traded in the U.S.

Inception Date: 03-30-2001 Telephone: 1-301-296-5100
Managers: MICHAEL PAUL BYRUM / MIKE DELLAPA
Web Site: www.guggenheiminvestments.com

Fundamentals for RYHCX

NAV (on 2014-07-22) 25.14
Assets (M) (on 2014-07-21) 122.15
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for RYHCX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2013-11-26) 0.04
Dividend Yield (ttm) 6.22

Fees & Expenses for RYHCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 2.37

Top Fund Holdings for RYHCX

Filing Date: 06/30/2014
Name Position Value % of Total
Johnson & Johnson 41,606 4,352,820 3.423%
Pfizer Inc 116,394 3,454,574 2.716%
Merck & Co Inc 56,020 3,240,757 2.548%
Gilead Sciences Inc 34,576 2,866,696 2.254%
AbbVie Inc 43,045 2,429,460 1.910%
Amgen Inc 20,153 2,385,511 1.876%
Bristol-Myers Squibb Co 47,056 2,282,687 1.795%
UnitedHealth Group Inc 27,774 2,270,525 1.785%
Biogen Idec Inc 6,906 2,177,531 1.712%
Celgene Corp 25,048 2,151,122 1.692%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil